0001011438-12-000203.txt : 20120508 0001011438-12-000203.hdr.sgml : 20120508 20120508145103 ACCESSION NUMBER: 0001011438-12-000203 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120331 FILED AS OF DATE: 20120508 DATE AS OF CHANGE: 20120508 EFFECTIVENESS DATE: 20120508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Consonance Capital Management LP CENTRAL INDEX KEY: 0001544773 IRS NUMBER: 260294313 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-14924 FILM NUMBER: 12821016 BUSINESS ADDRESS: STREET 1: 888 SEVENTH AVENUE STREET 2: 43RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 212.660-8062 MAIL ADDRESS: STREET 1: 888 SEVENTH AVENUE STREET 2: 43RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 13F-HR 1 form_13f-consonance.txt ----------------------------------- OMB APPROVAL ----------------------------------- OMB Number: 3235-0006 Expires: August 31, 2012 Estimated average burden hours per response..........22.6 ----------------------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F COVER PAGE Report for the Calendar Year or Quarter Ended: March 31, 2012 Check here if Amendment [ ]; Amendment Number: This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Consonance Capital Address: 888 Seventh Avenue, 43rd Floor New York, New York 10019 Form 13F File Number: The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Kevin H. Livingston Title: Managing Director Phone: 212-660-8060 Signature, Place, and Date of Signing: /s/ Kevin H. Livingston New York, New York May 8, 2012 ----------------------- -------------------- --------------- [Signature] [City, State] [Date] Report Type (Check only one.): [X] 13F HOLDINGS REPORT.(Check here if all holdings of this reporting manager are reported in this report.) [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) Form 13F Summary Page Report Summary: Number of Other Included Managers: 0 -------- Form 13F Information Table Entry Total: 13 -------- Form 13F Information Table Value Total: $124,435 -------- (thousands) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. No. Form 13F File Number Name --- -------------------- ----
Consonance Capital Form 13F Information Table Quarter ended March 31, 2012 COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8 VALUE SHRS or SH/ PUT/ INVE OTH VOTING AUTHORITY NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISC MAN SOLE SHARED NONE ---------------------------- -------------- --------- --------- --------- --- ---- ---- --- --------- ------ ---- ABAXIS INC COM 002567105 $ 6,456 221,621 SH SOLE 221,621 BIOSCRIP INC COM 09069N108 $ 9,293 1,368,640 SH SOLE 1,368,640 CHINDEX INTERNATIONAL INC COM 169467107 $ 2,034 214,092 SH SOLE 214,092 COMPUTER PROGRAMS & SYS INC COM 205306103 $ 10,198 180,437 SH SOLE 180,437 EXPRESS SCRIPTS INC COM 302182100 $ 10,706 197,600 SH SOLE 197,600 MEDICINES CO COM 584688105 $ 9,256 461,200 SH SOLE 461,200 OPTIMER PHARMACEUTICALS INC COM 68401H104 $ 9,833 707,444 SH SOLE 707,444 QUESTCOR PHARMACEUTICALS INC COM 74835Y101 $ 14,294 379,952 SH SOLE 379,952 SANTARUS INC COM 802817304 $ 12,410 2,121,370 SH SOLE 2,121,370 SHANGPHARMA CORP SPONSORED ADR 81943P104 $ 4,587 566,318 SH SOLE 566,318 UNITED THERAPEUTICS CORP DEL COM 91307C102 $ 10,906 231,400 SH SOLE 231,400 WUXI PHARMATECH CAYMAN INC SPONS ADR SHS 929352102 $ 7,619 529,100 SH SOLE 529,100 JAZZ PHARMACEUTICALS PLC SHS USD G50871105 $ 16,843 347,500 SH SOLE 347,500 Total Fair Market Value (in thousands): $124,435